Namir Hassan

CEO • Zelluna

Namir Hassan serves as CEO of Zelluna Immunotherapy. He has over 15 years of biotech and pharma industry experience spanning from target validation through to early phase clinical trials and has mostly focussed on Oncology and the development of TCR based immunotherapies. Prior to joining Zelluna, Namir was VP at Immunocore responsible for building and overseeing research biology and translational science for the Oncology pipeline then building a unit focussed on deployment of the platform in infectious diseases.

Previously, Namir had a leadership role in the discovery research organization within GSK and has worked at the Ludwig Institute for Cancer Research. Namir received a DPhil from the University of Oxford in T-cell Biology.

Also speaking

Amro Eid

Rachel Yao

Associate Director Technical Operations • SOTIO Biotech Inc

Hanna Lesch

CTO • Exothera SA

Event Info


Sponsorship Brochure

Take a look at the 2023 sponsorship opportunities here.

Agenda at a Glance

Check out the Agenda at a Glance for Advanced Therapies Europe 2023.